Differences in prostate cancer outcomes between cases with Gleason 4+3 and Gleason 3+4 tumors in a population-based cohort

PURPOSE: Reports on biochemical recurrence after prostate cancer (PCa) primary therapy have shown differences between Gleason 4+3 and 3+4 tumors. These findings have not been explored for PCa-specific mortality (PCSM). In this population-based cohort, we determine PCa outcomes at different Gleason s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Wright, Jonathan L., Salinas, Claudia A, Lin, Daniel W., Kolb, Suzanne, Koopmeiners, Joseph, Feng, Ziding, Stanford, Janet L
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2009
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2828768/
https://ncbi.nlm.nih.gov/pubmed/19836772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.08.026
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg